Step Counts for Weight Loss and Heart Health in Overweight/Obese Adults
This study is looking at how setting a specific daily step count can help overweight or obese adults lose weight and improve their heart health. Researchers will use your starting body weight and composition to set a personalized step goal, aiming for a 5% weight loss over 8 months. You'll use a pedometer to track your steps. The study is open to adults aged 20 and older who are otherwise healthy, even if they take medication for high blood pressure or osteoarthritis. They are looking for people who are generally sedentary or only walk regularly, and whose weight has been stable recently. The goal is to see if this approach can lead to predictable changes in body weight, body composition (the amount of fat and muscle in your body), and factors that affect heart health.
- Study design
- This interventional study plans to enroll 200 participants. It is not specified if it is randomized or blinded.
- What's involved
- In the first phase, you'll have weight and body composition measured at the start and again about a month later, and track steps daily for four weeks. In the second phase, you'll have measurements at the start, after four months, and after eight months, and track steps daily for the entire eight-month walking intervention.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your weight and body composition will be measured up to 8 months after the start of the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Robert Buresh, PhD · PRINCIPAL_INVESTIGATOR · Kennesaw State University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- weightIn phase one of the study, weight will be assessed at baseline (day 1), and 28-30 days later. In phase two of the study, weight will be measured 1) at baseline, 2) four months later, and 3) 8-months later
In phase one of the study, weight will be assessed for purposes of developing a regression model. In phase two of the study, weight will be assessed to establish a step count target, and to track changes during the 8-month intervention.
- body compositionIn phase one of the study, body composition will be assessed at baseline (day 1), and 28-30 days later. In phase two of the study, body composition will assessed 1) at baseline, 2) 4 months later, and 3) 8 months later
In phase one of the study, body composition (percentage of body weight comprised of fat) will be determined for the purposes of developing a regression model to allow prediction of body composition. In phase two of the study, body composition (percentage of body weight comprised of fat) will be assessed to determine baseline levels, and to allow for tracking changes over the 8-month intervention.
- Step countsIn phase one of the study, step counts will be recorded every day for 4 weeks. In phase two of the study, step counts will be recorded each day for the duration of the 8-month walking intervention
Step counts (steps per day) will be recorded using pedometers that will be carried on the hips or torso. Step counts will be recorded for four weeks during phase one of the study, and for eight months during the intervention phase of the study (phase two).